{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-085361","form_type":"8-K","ticker":null,"cik":"0000786947","company_name":"ACURA PHARMACEUTICALS, INC","filed_at":"2023-07-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.647829+00:00","generated_at":"2026-06-12T23:26:02.177754+00:00","sec_items":["1.01","2.01","2.03","9.01"],"event_type":"debt","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Acura receives $250K related-party loan; warns may need to terminate operations by end of August 2023","bullets":["Received $250K loan from AD Pharma; total note now $3,919,279, matures Dec 31, 2023 at 5.25%.","AD Pharma holds 66% of common; its managing partner Mr. Schutte directly owns 14%.","Proceeds cover operations only through August 2023; no assurance of additional financing; may need to scale back or seek bankruptcy.","Default interest rate 7.5% per annum on overdue amounts."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-085361","json":"https://secwatch.observer/filing/0001104659-23-085361.json","markdown":"https://secwatch.observer/filing/0001104659-23-085361.md","text":"https://secwatch.observer/filing/0001104659-23-085361.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/786947/000110465923085361/0001104659-23-085361-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/786947/000110465923085361/tm2322359d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T23:26:02.177754+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"da4df6b88fe71b51330237a1cb3f20fcfa9ef9b9","claim":"ACURA PHARMACEUTICALS, INC incurred loan of $250,000 with Abuse Deterrent Pharma, LLC at 5.25% maturing December 31, 2023.","evidence_excerpt":"On July 28, 2023 we received a $250,000 loan from Abuse Deterrent Pharma, LLC (\"AD Pharma\").","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/786947/000110465923085361/0001104659-23-085361-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"loan"},{"label":"Principal","value":"$250,000"},{"label":"Counterparty","value":"Abuse Deterrent Pharma, LLC"},{"label":"Rate","value":"5.25%"},{"label":"Maturity","value":"December 31, 2023"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}